Treatment of pollen allergy with high-potency homeopathy C 50,000 (HP50) and voice frequency analysis (VFA) as controlling method—Controlled trial practice with 15 patients

Abstract

Objective A controlled practical study should clarify whether pollen allergy patients treated with specific immunotherapy (SIT) targeted to immunological stress response and still suffering from pollen allergy symptoms improve under treatment with high-potency homeopathy C 50,000 (HP50). Method of measurement To determine the patient's individual emotional and functional responses and their involvement in the allergy-related psycho-social environment (PSE), the diagnosis system Voice Frequency Analysis (VFA) by Heinen (Poster 84, 85 Allergo J. 16/2007, 582) was applied in addition to sensitivity- and symptom-scores. Treatment method High-potency homeopathy C 50,000 (HP50) of individualized drugs Design of study Treatment of 15 patients with pre-treatment of SIT and remaining symptoms. VFA-measurements: 4 weeks before HP50, day of first HP50, day of last HP50, during maximum pollination in 2008 and 2009. The control groups contained 16 healthy persons and 20 pollen allergy patients treated with placebo (NaCl). Hypothesis HP50 can significantly improve the effect of SIT and improve and stabilize the success of treatment on a 1 year basis. Discussion The study suggests, that HP50, which in addition to SIT concerns the patient's individual emotional and functional responses and thereby the entire internal and external milieu of the organism, stabilizes pollen allergy patients on a long-term basis. The individualized emotional–functional diagnosis by VFA is an appropriate tool to monitor this finding. The additional attention to individual emotional and functional responses – in the sense of an integrated medicine – can to be of great importance for success in the treatment of pollen allergy patients.